Bio! News December 2012 – A

Bio! News

December 2012 – A

From: Ketzer, et al., (2012).
A recent study reports the potential of synthetic riboswitches to treat cancer. Researchers used oncolytic viral vectors -i.e., viral vectors designed to proliferate specifically in tumor cells- and riboswitches to tune the expression of a therapeutic gene. Ribozymes are specially interesting because, in contrast to other regulatory elements, they do not elicit an immunological response and do  not require much space in the vector.


From: Huang, S., et al., (2012).
MED12, a TGF-beta regulatory protein, is reported to be involved in cancer drug resistance. When MED12 is mutated, TGF-beta signaling -a pathway known to be related to drug resistance- remains active.
DNA fibers were imaged trough transmission electron microscopy (TEM) using micropatterned devices that allowed the deposition of DNA fibers suitable for TEM imaging with less background noise. 

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión / Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión / Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión / Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión / Cambiar )

Conectando a %s